New injection tested for serious lung blood pressure disease
Disease control
Completed
This study tested whether adding KER-012 injections to standard medications helps adults with pulmonary arterial hypertension, a serious condition where blood pressure is high in the lungs. 113 participants received either KER-012 or a placebo shot every 4 weeks for 24 weeks whil…
Phase: PHASE2 • Sponsor: Keros Therapeutics, Inc. • Aim: Disease control
Last updated Mar 12, 2026 13:51 UTC